Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Parametric Response Mapping of Co-Registered Ivim MRI and PET to Identify Radioresistant Sub-Volumes in Locally Advanced Cervical Carcinoma Undergoing CCRT. International journal of radiation oncology, biology, physics Capaldi, D. P., Wang, J. Y., Liu, L., Sheth, V., Kidd, E. A., Hristov, D. H. 2023; 117 (2S): e648

Abstract

PURPOSE/OBJECTIVE(S): To investigate parametric response mapping (PRM) of co-registered positron emission tomography (PET) and intravoxel incoherent motion (IVIM) MRI in locally advanced cervical carcinoma patients to identify sub-volumes that may predict treatment response to adjuvant concurrent chemoradiation therapy (CCRT).MATERIALS/METHODS: Pre- and on-treatment (after four weeks of CCRT) diffusion weighted images (DWIs) MRI and pre-treatment PET were performed on 20 cervical cancer patients (median [range] age: 63 [41 to 85]; FIGO staging: 3 IIB, 1 IIIB, 10 IIIC1, 4 IIIC2, 2 IVA; histology: 11 squamous cell carcinoma, 4 endocervical adenocarcinoma; LN status: 4 negative, 16 positive). IVIM MRI maps were generated by Bayesian fitting of a two-compartment IVIM model to the DWIs to produce three-dimensional diffusion coefficient (D) and perfusion fraction (f). Three-dimensional IVIM D and f maps were co-registered to PET standardized uptake value (SUV) maps. Population means of PET SUV, IVIM D and f from pre-treatment scans were calculated to generate thresholds to identify low versus high metabolic (muSUV) regions, low versus high diffused (muD) regions as well as low versus high perfused (muf) regions, respectively. PRM maps were generated using voxel-wise joint histogram analysis to classify voxels within the tumor as highly metabolic and with low cellular density (SUVD), highly metabolic and with high cellular density (SUVD), metabolically inactive and with high cellular density (SUVD), or metabolically inactive and with low cellular density (SUVD) tissue based on the population mean thresholds. Similar PRM maps were generated using the joint histogram analysis with SUV and f. Summary statistics for these and other imaging parameters were calculated pre- and on-treatment. Univariate analysis was performed to determine relationships between relative change in gross tumor volume (DeltaGTV) and pre-treatment imaging measurements.RESULTS: In tumors, on- versus pre-treatment tumor volume (p<.001) significantly decreased, while IVIM f (p?=?.002) and D (p?=?.03) significantly increased. Pre-treatment tumor volume (r?=?.45, p?=?.04) and PRM SUVD (r?=?.65, p?=?.002) regions were positively related with DeltaGTV, while pre-treatment IVIM D (r?=?-.64, p?=?.002), PRM SUVf (r?=?-.52, p?=?.02) and PRM SUVD (r?=?-.74, p<.001) regions were negatively related with DeltaGTV. The latter PRM result suggests that larger regions of low cellular density (as represented by elevated D)?+?low metabolism result in a reduced change in tumor volume on-treatment, potentially representing a radioresistant sub-volume.CONCLUSION: PRM, generated from PET and IVIM MRI, was applied to patients with locally advanced cervical carcinoma and radioresistant sub-volumes were identified which may predict treatment response. The complementary information provided from PET and IVIM, combined using PRM, may assist in decision-making to individualize therapies, such as with image guided brachytherapy, to improve patient outcomes.

View details for DOI 10.1016/j.ijrobp.2023.06.2067

View details for PubMedID 37785926